USPTO serial 87135851
CIRINA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVOIE, RYAN CHRISTOPHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CIRINA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John L. Slafsky
John L. Slafsky Wilson Sonsini Goodrich & Rosati650 Page Mill RoadPalo Alto, CA 94304-1050UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; assays and reagents for scientific and research use; diagnostic reagents and preparations for scientific use; diagnostic test kits comprised of proteins, buffers, primers, standards, reagents, enzymes for use in genomic testing for use in the fields of scientific, pharmaceutical and medical research; diagnostic test kits comprised of proteins, buffers primers, standards, reagents, enzymes for use in genomic testing for scientific use; chemical reagents for non-medical purposes; chemical test kits comprised of proteins, buffers, primers, standards, reagents, enzymes for use in genomic testing for scientific, clinical or medical laboratory use; chemical reagents for proteins, buffers, primers, standards, reagents, enzymes and kits containing same comprised of proteins, buffers, primers, standards, reagents, enzymes for use in genomic testing, each for scientific purposes; clinical diagnostic reagents; reagents, enzymes, and nucleotides for medical research use; reagent kits comprised of proteins, buffers, primers, standards, reagents, enzymes and beads with attached biomolecules for clinical diagnostic purposes | ACTIVE | — |
| 009 | Scientific, surveying, optical, weighing apparatus and instruments; scientific, surveying, optical measuring apparatus and instruments, namely, genomic analysis instrumentation; apparatus for recording, transmission or reproduction of sound or images; data processing equipment, computers; computer hardware systems and software for laboratory testing and diagnostics; automated laboratory apparatus and computer systems for use in analysis of biomolecules; nucleic acid sequencers; non-medical imaging devices for diagnostic testing; laboratory equipment, namely, imaging devices; computer software for data collection, management, and analysis of genetic information for use in the field of diagnostic and clinical research and for clinical diagnostic purposes and scientific research; computer software for use in database management for laboratory testing and diagnostics; scientific measuring apparatus and instruments, namely, genomic analysis instruments; scientific equipment and instruments namely, genomic analysis instrumentation; laboratory equipment, namely, genomic analysis instrumentation; computer readable medical reports recorded on magnetic and optical media, namely CDs, DVDs, cloud based storage solutions; biotechnology related software, namely, genomic analysis software; biotechnology data collection software; DNA testing apparatus which carry and hold DNA samples for scientific research | ACTIVE | — |
| 010 | Medical imaging devices for any part or organ of the body; DNA testing apparatus which carry and hold DNA samples for medical treatment uses; Distribution services, namely, delivery of pharmaceutical and health care products | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of laboratory test and diagnostics; scientific research and development in the field of laboratory testing and diagnostics; medical research in the field of laboratory testing and diagnostics; design and development of computer hardware and software; DNA screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and research related thereto; computer services, namely, e.g., designing and implementing clinical reports or medical records, web pages for others, internet protocol address management; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; consulting services in the field of life science research, diagnostics, and biotechnology; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules for research purposes; product development in the fields of scientific and clinical research; diagnostic, forensic, and genetic medical testing services for others for research purposes; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, namely, research, testing, and chemical screening and diagnostic services for others; product research and development for others, and design for others, all in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology related services, namely, biotechnology research, consulting services in the field of life science research, diagnostics, and biotechnology; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals for research purposes; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; chemical screening analysis and diagnostic, forensic, and genetic medical testing services for others for research purposes; research and development services for others in the field of chemicals and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, namely, research, testing, and chemical screening and diagnostic services for others; research, development, and design of pharmaceutical and health care products for the treatment of life threatening diseases such as cancer, gene sequencing services utilizing testing probes containing biochemical marker labels and analytic software for research purposes; analyzing of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality and specification of same for research purposes | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals; medical diagnostic testing and reporting services; scientific and medical research; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; consulting services in the field of research, diagnostics and medical care; consultancy, information and advisory services in the field of analysis of biomolecules for medical purposes; diagnostic, forensic, and genetic medical testing services for others for treatment purposes; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals for medical treatment purposes; chemical screening analysis and diagnostic, forensic, and genetic medical testing services for others for medical treatment purposes; analyzing of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality and specification of same for medical treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cirina Limited
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CIRINA
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 5, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 9, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 2, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 11, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 16, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 23, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2016 | NWAP | NEW APPLICATION ENTERED | — |